Business
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of
About this update from Lifeward Ltd.
[{"type":"text","content":"MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) (\"ReWalk\" or the \"Company\"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the ReStore Exo-Suit for stroke rehabilitation has received CE marking, clearing it for sale to rehabilitation clinics in the European Union. This CE Mark is the first clearance of a soft exo-suit, a next generation medical device which can serve a larger and more diverse patient population facing mobility challenges. \n\n \nReStore's soft, garment-like design allows variability of movement which combines with first-of-its-kind plantarflexion propulsion assistance that adaptively synchronizes with the patient's natural gait to facilitate functional gait training activities. The device also provides therapists the ability to adjust and optimize a patient's treatment using real-time analytics. \n\"The ReStore revolutionizes post stroke gait training, providing key advantage to clinics, therapists and patients,\" said ReWalk CEO Larry Jasinski. ''We developed this design through collaboration with the Wyss Institute at Harvard because of the unique opportunity to combine extensive depth of the supporting science and clinician involvement in designing the ideal system for stroke therapy in the clinic.\" \nThe company announced that ReStore will be priced significantly lower than the first generation of rigid exoskeleton technologies, and can be used to treat a broad range of stroke rehabilitation patients. ReWalk will offer direct purchase and third party leasing programs for the ReStore in the EU.\n\"The device's affordability and versatility make an attractive solution for a broader range of the rehabilitation market than previous technologies,\" Jasinski added. \"Considering the high prevalence of stroke and the need for more effective and efficient clinical solutions, the marketplace for the ReStore is significant and holds immense promise for the continued innovation of care.\"\nStroke is a leading cause of disability which affects 17 million people worldwide each year.(1) As many as 80% of stroke survivors suffer from locomotor dysfunction, which is characterized as asymmetrical step length, slow velocity, and altered biomechanical alignment.(2)\nReStore is ReWalk's second marqu...